Literature DB >> 30069682

Association of interleukin 6, interleukin 7 receptor alpha, and interleukin 12B gene polymorphisms with multiple sclerosis.

Yvonne Benešová1, Anna Vašků2, Julie Bienertová-Vašků2.   

Abstract

Pro-inflammatory and anti-inflammatory cytokines have been shown to play a crucial role in the pathophysiology of multiple sclerosis (MS). We investigated the association between interleukin (IL) IL6-174 G/C (rs1800795), IL7RA C/T (rs6897932), and IL-12B A1188C (rs3212227) gene polymorphisms (SNPs) and MS. The study consisted of 297 unrelated MS patients and 135 healthy individuals. In IL6-174G/C (rs1800795), a significant association between the C allele and MS risk [OR 1.41, 95% CI (1.05-1.92); P = 0.025] was found. Carriage of genotypes CC and CG were more common in MS patients [OR 1.58, 95% CI (1.04-2.39); P = 0.031] and also in female MS patients [OR 1.68, 95% CI (1.02-2.79); P = 0.043]. However, after applying Bonferroni's correction the differences did not remain significant. No significant association between the IL7RA C/T (rs6897932) and IL12B A1188C (rs3212227) gene polymorphisms and MS susceptibility was observed. Regarding IL-12B A1188C (rs3212227), a significant association between the CC genotype and MS progression, expressed as MSSS, was demonstrated in the female MS group. Our results indicate that the distribution of IL6-174G/C (rs1800795) SNP was marginally associated with MS susceptibility. We also showed that IL-12B A1188C (rs3212227) can contribute to the progression of the disease in the Czech population.

Entities:  

Keywords:  Gene; Interleukin 12B; Interleukin 6; Interleukin 7 receptor alpha chain; Multiple sclerosis; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2018        PMID: 30069682     DOI: 10.1007/s13760-018-0994-9

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  4 in total

Review 1.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

Review 2.  Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.

Authors:  Dharmendra Kumar Khatri; Amey Kadbhane; Monica Patel; Shweta Nene; Srividya Atmakuri; Saurabh Srivastava; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-08

3.  Interleukin 6 SNP rs1818879 Regulates Radiological and Inflammatory Activity in Multiple Sclerosis.

Authors:  Antonio Bruno; Ettore Dolcetti; Federica Azzolini; Alessandro Moscatelli; Stefano Gambardella; Rosangela Ferese; Francesca Romana Rizzo; Luana Gilio; Ennio Iezzi; Giovanni Galifi; Angela Borrelli; Fabio Buttari; Roberto Furlan; Annamaria Finardi; Francesca De Vito; Alessandra Musella; Livia Guadalupi; Georgia Mandolesi; Diego Centonze; Mario Stampanoni Bassi
Journal:  Genes (Basel)       Date:  2022-05-17       Impact factor: 4.141

4.  Expression and clinical significance of IL7R, NFATc2, and RNF213 in familial and sporadic multiple sclerosis.

Authors:  Seyedeh Zahra Hosseini Imani; Zohreh Hojati; Sheyda Khalilian; Fariba Dehghanian; Majid Kheirollahi; Mehdi Khorrami; Vahid Shaygannejad; Omid Mirmosayyeb
Journal:  Sci Rep       Date:  2021-09-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.